Literature DB >> 6192039

Liver injury with alcoholiclike hyalin after gastroplasty for morbid obesity.

D L Hamilton, T K Vest, B S Brown, A N Shah, R B Menguy, W Y Chey.   

Abstract

Hepatic damage resembling alcoholic hepatitis has been described after jejunoileal bypass surgery for morbid obesity, but has not been previously reported as a complication of gastric partitioning operations (gastric bypass and gastroplasty). A patient who developed an alcoholic hepatitislike clinical picture 8 mo after gastroplasty is described, suggesting that malnutrition superimposed on obesity may be responsible for the injury in both settings. Reversal of the gastroplasty was associated with clinical and biochemical improvement.

Entities:  

Mesh:

Year:  1983        PMID: 6192039

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Modified jejunoileal bypass surgery with biliary diversion for morbid obesity and changes in liver histology during follow-up.

Authors:  Iraj Fazel; Akram Pourshams; Shahin Merat; Roya Hemayati; Masoud Sotoudeh; Reza Malekzadeh
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

2.  Therapeutic Options in Nonalcoholic Fatty Liver Disease.

Authors:  Jeffrey L. Tokar; Carl L. Berg
Journal:  Curr Treat Options Gastroenterol       Date:  2002-12

3.  Nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: association of pancreatic exocrine deficiency and infection.

Authors:  Yasuhiro Murata; Shugo Mizuno; Hiroyuki Kato; Masashi Kishiwada; Ichiro Ohsawa; Takashi Hamada; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata; Keisuke Nishimura; Kazuo Fukutome; Shuji Isaji
Journal:  Clin J Gastroenterol       Date:  2011-06-10

Review 4.  Non-alcoholic fatty liver disease: an emerging pathological spectrum.

Authors:  Elie Serge Zafrani
Journal:  Virchows Arch       Date:  2003-12-18       Impact factor: 4.064

5.  Long-term consequences after jejunoileal bypass for morbid obesity.

Authors:  M P Hocking; G L Davis; D A Franzini; E R Woodward
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 6.  From the origin of NASH to the future of metabolic fatty liver disease.

Authors:  Andreas Geier; Dina Tiniakos; Helmut Denk; Michael Trauner
Journal:  Gut       Date:  2021-02-25       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.